Keyword: Effectiveness


Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Introduction: Spasticity is a common symptom among patients with multiple sclerosis (MS). This study aims to assess the effectiveness and safety of the combination of delta-9- tetrahydrocannabinol (THC) and cannabidiol…

THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms

Background: The prospective observational MObility ImproVEment (MOVE) 2 study is collecting real-life clinical outcomes data on patients with treatment-resistant multiple sclerosis (MS) spasticity treated with THC:CBD oromucosal spray in routine…